{"groups":[{"description":"1. Fludarabine 30 mg\\^m2 on days -7, -6, -5, -4 \\& -3\n2. Melphalan 140 mg\\^m2 on day -2\n3. Rabbit antithymocyte globulin (ATG) 6mg/kg divided over 3 days, Days -4,-3,-2. (Thymoglobulin 1.0mg/kg on day -4, and 2.5mg/kg/d on days -3, -2)\n4. Tacrolimus starting on day -1 as a continuous infusion of 0.03 mg/kg/d.\n5. Mycophenolate mofetil (MMF) IV 15mg/kg BID will start on Day 0","id":"FG000","title":"Umbilical Cord Blood Transplantation"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"5"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"5"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"There were no group assignments for this study. It was a single arm cord blood transplant study.","recruitmentDetails":"Study was IRB approved on 6/8/06. The first patient was enrolled on 6/9/06. The last patient was enrolled on 12/22/08."}